UG Healthcare Corporation Limited (8K7.SI)
SGD 0.12
(-2.5%)
SGD 0.12
(-2.5%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.15 Million | -39.14 Million | 53.95 Million | 81.16 Million | 10.98 Million | -6.36 Million |
| Net Income | -9.08 Million | -20.73 Million | 48.76 Million | 159.4 Million | 18.05 Million | 2.76 Million |
| Depreciation & Amortization | 3.87 Million | 3.47 Million | 3.9 Million | 3.03 Million | 2.46 Million | 1.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.13 Million | 2.08 Million | 19.65 Million | -50.13 Million | -7.78 Million | -7.65 Million |
| Other non-cash items | -1.8 Million | -23.96 Million | -18.37 Million | -31.13 Million | -1.74 Million | -3.1 Million |
| Investing Cash Flow | -22.73 Million | -8.02 Million | -21.19 Million | -18.88 Million | -2.84 Million | -6.88 Million |
| Investments in PPE | -2.55 Million | -8.02 Million | -22.32 Million | -19.69 Million | -3.28 Million | -8.59 Million |
| Acquisitions | -22.52 Million | - | 133 Thousand | 31 Thousand | - | - |
| Investment purchases | -732 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.3 Million | - | 995 Thousand | 778 Thousand | 441 Thousand | 1.7 Million |
| Financing Cash Flow | 8.36 Million | 8.69 Million | -973 Thousand | -3.14 Million | -3.73 Million | 11.39 Million |
| Debt repayment | -9.1 Million | -13.49 Million | -20.45 Million | -30.68 Million | -82.36 Million | -69.7 Million |
| Dividends payments | - | -3.99 Million | -1.21 Million | -1.08 Million | -104 Thousand | -103 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 18.43 Million | - | - |
| Other Financing Activities | -742 Thousand | 26.18 Million | 20.69 Million | 10.19 Million | 78.73 Million | 81.19 Million |
| Accounts receivables | -15.68 Million | 5.21 Million | 19.33 Million | -27.73 Million | -9.39 Million | 1.06 Million |
| Accounts payables | 4.09 Million | -10.41 Million | -10.24 Million | 16.28 Million | 4.3 Million | 579 Thousand |
| Inventory | 2.48 Million | 7.29 Million | 10.57 Million | -38.68 Million | -2.69 Million | -9.29 Million |
| Other working capital | 2.06 Million | - | - | - | - | - |
| Cash at beginning of period | 61.14 Million | 100.21 Million | 67.79 Million | 8.66 Million | 4.25 Million | 6.11 Million |
| Cash at end of period | 27.39 Million | 61.74 Million | 99.58 Million | 67.79 Million | 8.66 Million | 4.25 Million |
| Capital Expenditure | -2.55 Million | -8.02 Million | -22.32 Million | -19.69 Million | -3.28 Million | -8.59 Million |
| Effect of forex changes on cash | -1.23 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -33.75 Million | -38.47 Million | 31.78 Million | 59.13 Million | 4.4 Million | -1.86 Million |
| Free Cash Flow | -20.7 Million | -47.17 Million | 31.62 Million | 61.46 Million | 7.7 Million | -14.96 Million |
| Breakdown | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.05 Million | -4.97 Million | -15.95 Million | -20.73 Million | -4.77 Million | 48.76 Million |
| Depreciation & Amortization | 3.87 Million | 1.76 Million | 1.9 Million | 3.47 Million | 1.57 Million | 3.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -19.29 Million | -9.64 Million | 7.36 Million | 2.08 Million | -5.28 Million | 19.65 Million |
| Other non-cash items | 23.64 Million | 13.31 Million | -18.51 Million | -23.96 Million | -591 Thousand | -18.37 Million |
| Investing Cash Flow | -21.02 Million | -1.11 Million | -1.5 Million | -8.02 Million | -6.52 Million | -21.19 Million |
| Investments in PPE | -21.02 Million | -1.11 Million | -1.5 Million | -8.02 Million | -6.52 Million | -22.32 Million |
| Acquisitions | - | - | - | - | - | 133 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 995 Thousand |
| Financing Cash Flow | 12.15 Million | -2.78 Million | 7.4 Million | 8.69 Million | 1.29 Million | -973 Thousand |
| Debt repayment | -12.88 Million | -2.64 Million | -7.79 Million | -13.49 Million | -5.69 Million | -20.45 Million |
| Dividends payments | - | - | - | -3.99 Million | -3.99 Million | -1.21 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -141 Thousand | -392 Thousand | 26.18 Million | -409 Thousand | 20.69 Million |
| Accounts receivables | -17.72 Million | -16.11 Million | 5.02 Million | 5.21 Million | 182 Thousand | 19.33 Million |
| Accounts payables | 4.09 Million | -1.52 Million | -2.7 Million | -10.41 Million | -7.71 Million | -10.24 Million |
| Inventory | -5.66 Million | 8 Million | 5.04 Million | 7.29 Million | 2.25 Million | 10.57 Million |
| Other working capital | - | 1.00 | - | - | - | - |
| Cash at beginning of period | 61.74 Million | 61.74 Million | 77.48 Million | 100.21 Million | 100.21 Million | 67.79 Million |
| Cash at end of period | 27.99 Million | 45.12 Million | 61.74 Million | 61.74 Million | 77.48 Million | 99.58 Million |
| Capital Expenditure | -21.02 Million | -1.11 Million | -1.5 Million | -8.02 Million | -6.52 Million | -22.32 Million |
| Effect of forex changes on cash | - | 1000.00 | 1000.00 | - | -1000.00 | - |
| Net cash flow / Change in cash | -33.74 Million | -16.61 Million | -15.73 Million | -38.47 Million | -22.73 Million | 31.78 Million |
| Free Cash Flow | -45.89 Million | -13.83 Million | -23.14 Million | -47.17 Million | -24.02 Million | 31.62 Million |
KDLY
603289
MAHALXSE
9346
BOXL
LKNCY